Contributions of HalfLifeHavel

Contributions by HalfLifeHavel, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 1,311 edits includes activity predating the current log.

1. 01:33, 25 Oct 2025 (diff | hist) Hubei Jianxiang Bioscience 9,989 +271 m label community tally as self-reported
2. 18:44, 3 Sep 2025 (diff | hist) Glucose-dependent insulinotropic polypeptide 8,265 ±0 add DOI
3. 19:24, 10 Jul 2025 (diff | hist) Xi'an Mokemei Biotechnology 6,944 ±0 add citation for the incidence figure
4. 09:54, 25 Jun 2025 (diff | hist) Incretin effect 6,953 ±0 m label community tally as self-reported
5. 23:06, 24 Jun 2025 (diff | hist) Beyond-use date 15,368 ±0 m replace bare ref with full citation
6. 16:40, 24 May 2025 (diff | hist) Incretin effect 5,933 ±0 m state the assay for the reference interval
7. 19:07, 11 Mar 2025 (diff | hist) Lyophilisation 17,659 +17 ce per MOS
8. 17:10, 1 Mar 2025 (diff | hist) Glucagon-like peptide-1 10,239 +47 m add DOI
9. 06:55, 2 Nov 2024 (diff | hist) Glucagon-like peptide-1 7,886 +44 expand §Therapeutic exploitation
10. 00:10, 12 Oct 2024 (diff | hist) Glucagon-like peptide-1 7,221 ±0 correct percentage: source reports placebo-adjusted
11. 00:55, 24 Jul 2024 (diff | hist) Incretin effect 2,353 ±0 rv addition of price information per PP:VN
12. 08:12, 22 Jul 2024 (diff | hist) Enteroendocrine L cell 2,224 ±0 m remove weasel wording
13. 07:59, 9 Jul 2024 (diff | hist) Incretin effect 2,353 +512 undo good-faith edit: the source does not say this
14. 14:17, 20 Jun 2024 (diff | hist) Glucagon-like peptide-1 1,486 ±0 split overlong sentence
15. 10:21, 19 Jun 2024 (diff | hist) Glucose-dependent insulinotropic polypeptide 1,758 ±0 move unsourced paragraph to talk